Assessment of synovial fluid biomarkers in healthy foals and in foals with tarsocrural osteochondrosis.

This study examines the changes in synovial fluid biomarkers in foals with osteochondrosis, specifically looking at cartilage turnover, enzymes, growth and transformation factors, and inflammatory markers. The research indicates an anabolic shift in type II collagen turnover in juvenile joints with osteochondrosis. Early stage lesions seemed to be associated with reduced levels of the insulin-like growth factor-1.

Research Context and Purpose

• The study was conducted on foals aged 18, 22, and 52 weeks to identify alterations in the biomarkers in synovial fluid (SF), including type II collagen, proteoglycan, matrix metalloproteinase (MMP) activity, insulin-like growth factor (IGF)-1, transforming growth factor (TGF)-β1, prostaglandin (PG) E(2), and leukotriene B(4). The study was particularly interested in how these biomarkers changed in relation to osteochondrosis (OC), a joint condition in foals.

Findings

• A higher CPII:C2C ratio – biomarkers for type II collagen turnover – was found to be a consistent feature in the affected foals at all ages, suggesting higher cartilage turnover in OC-affected joints. This difference was particularly noticeable at 22 weeks.
• At 18 weeks, OC-affected joints had reduced concentrations of CS846 and IGF-1, and the CS846:GAG ratio, indicating a possible association of these biomarkers with early-stage OC.
• At 52 weeks, the PG E(2) concentration, an inflammatory marker, was lower in OC-affected joints, suggesting inflammation could be lesser in the affected joints at this age.
• The proteoglycan turnover (indicated by CS846), considered an important factor in joint health, did not show a remarkable difference in OC-affected joints, suggesting this was not a key factor in the development or progression of OC.

Conclusions

• The study concludes that an anabolic shift in type II collagen turnover is a consistent occurrence in juvenile joints with OC. This means that new collagen is being produced and broken down at a higher rate in these OC-affected joints.
• The study also suggests that reduced concentrations of IGF-1 in SF might be associated with early-stage OC lesions, potentially offering a biomarker for early identification of OC.
• Proteoglycan turnover does not appear to be a signature characteristic in late OC lesions, contrary to some previous beliefs about the nature of OC.